Oral Vaccine Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Vaccine Type (Live vaccine, Inactive Vaccine, Recombinant Vaccine, Others); Application (Polio, Rabies, Tuberculosis, Influenza, Respiratory infections, HIV, Others); End User (Hospitals, Government vaccination programs, Research institutes, Others) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

The Oral Vaccine Market is expected to register a CAGR of 9.4% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The Oral Vaccine Market report covers analysis by Vaccine Type (Live vaccine, Inactive Vaccine, Recombinant Vaccine, Others); Application (Polio, Rabies, Tuberculosis, Influenza, Respiratory infections, HIV, Others); End User (Hospitals, Government vaccination programs, Research institutes, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.

Purpose of the Report

The report Oral Vaccine Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

• Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
• Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
• Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Oral Vaccine Market Segmentation

Vaccine Type

• Live vaccine
• Inactive Vaccine
• Recombinant Vaccine

Application

• Polio
• Rabies
• Tuberculosis
• Influenza
• Respiratory infections
• HIV

End User

• Hospitals
• Government vaccination programs
• Research institutes

Oral Vaccine Market Growth Drivers

• Increasing Demand for Non-Invasive Vaccine Administration: An emerging trend favoring non-invasive vaccination techniques fuels the oral vaccine market. Oral vaccines eliminate the use of needles and injections, making them more comfortable for children and people with needle phobia. Such ease is leading to widespread adoption as a preferred alternative, especially in regions where injectable vaccines are the norm.
• Easy Accessibility of Vaccines in Developing Regions: Logistical challenges in many developing countries include refrigeration and availability of trained healthcare providers who would administer injectable vaccines thus limiting the number of people vaccinated. Oral vaccines that are easier to store and administer will solve the problem. The significance of increasing vaccination in underprivileged regions has thus triggered a lot of demand for oral vaccine solutions, especially for rotavirus and polio.
• Advances in Oral Vaccine Delivery Technology: Technological advancements in vaccine formulations and delivery systems are driving the growth of the oral vaccine market. Innovations in stabilizing vaccine ingredients for oral administration, such as encapsulation technologies and controlled-release formulations, have significantly improved the effectiveness and shelf-life of oral vaccines. These developments are overcoming previous limitations of oral vaccines, boosting their market potential.

Oral Vaccine Market Future Trends

• Popularity of vaccine self-administration: Self-medication and home-based healthcare have become increasingly common, and people are now seeking vaccines that they can administer to themselves, particularly for routine vaccinations. Oral vaccines are at the forefront of this trend, which injectable vaccines cannot match. This is highly relevant in developed markets where the need for self-control over health care is greater.
• Expanding Applications Beyond Traditional Diseases: Oral vaccines are not only limited to polio, rotavirus, and other diseases, but in recent times, research has also been underway for oral vaccines in other areas such as respiratory infections, HIV, and malaria. This has created a growth-oriented market because these oral vaccines are being developed for diseases that have significant global health impacts. Studies are also underway in potential emerging fields like cancer immunotherapy for oral vaccines, thereby expanding their application.
• Vaccine education and public trust: As vaccine hesitancy continues to grow, public education on the safety and efficacy of vaccines, including oral vaccines, is also on the rise. Governments, healthcare providers, and advocacy organizations have ramped up efforts to increase public confidence in vaccines, enabling increased adoption and further market growth.

Oral Vaccine Market Opportunities

• Oral Vaccines for Infectious Diseases Development: While oral vaccines for diseases like polio and rotavirus already exist, new opportunities are rising in developing oral vaccines for infectious diseases with very high unmet needs. If vaccines for respiratory diseases, HIV, and malaria could be orally administered, these would significantly change the global scenario of vaccination efforts. Investment in R&D toward developing these vaccines is a sizeable opportunity for pharmaceutical companies.
• Oral Vaccine Use in Travel and Tourism Health Programs: With increasing international travel, oral vaccines are now a great opportunity to be integrated into the travel health program. Oral vaccines will be of convenience to tourists visiting regions of high risk such as cholera, typhoid, and yellow fever since they are more convenient to administer and more attractive to the public than injectable vaccines.
• Incorporation with Digital Health and Monitoring Technologies: Oral vaccines may have integration with digital health platforms and therefore create an avenue for future market growth. It may provide opportunities to better monitor schedules for vaccination, health outcomes tracking, and provision of digital reminders using mobile apps that improve management and compliance with oral vaccine programs. Remote monitoring via digital tools might improve the uptake of vaccines and ensure proper delivery to underserved populations.

Oral Vaccine Market Regional Insights

The regional trends and factors influencing the Oral Vaccine Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Oral Vaccine Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Oral Vaccine Market Report Scope

Oral Vaccine Market Players Density: Understanding Its Impact on Business Dynamics

The Oral Vaccine Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Oral Vaccine Market are:

1. Serum Institute of India Pvt. Ltd
2. GlaxoSmithKline Plc
3. Merck and Co. Inc
4. Aventis
5. PaxVax Corporation
6. VALNEVA Canada Inc

Disclaimer: The companies listed above are not ranked in any particular order.

Key Selling Points

• Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Oral Vaccine Market, providing a holistic landscape.
• Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
• Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
• Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Oral Vaccine Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

The List of Companies

1.Serum Institute of India Pvt. Ltd
2.GlaxoSmithKline Plc
3.Merck and Co. Inc
4.Aventis
5.PaxVax Corporation
6.VALNEVA Canada Inc
7.Janssen Pharmaceuticals
8.Shanghai BravoBio Co., Ltd
9.Swiss Serum and Vaccine Institute Berne
10.QUÍMICA SUIZA S.A